158 related articles for article (PubMed ID: 20153314)
1. Effects of cannabinoid receptor antagonists on maintenance and reinstatement of methamphetamine self-administration in rhesus monkeys.
Schindler CW; Panlilio LV; Gilman JP; Justinova Z; Vemuri VK; Makriyannis A; Goldberg SR
Eur J Pharmacol; 2010 May; 633(1-3):44-9. PubMed ID: 20153314
[TBL] [Abstract][Full Text] [Related]
2. The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse.
Ward SJ; Rosenberg M; Dykstra LA; Walker EA
Drug Alcohol Depend; 2009 Dec; 105(3):248-55. PubMed ID: 19679410
[TBL] [Abstract][Full Text] [Related]
3. Contextual renewal of nicotine seeking in rats and its suppression by the cannabinoid-1 receptor antagonist Rimonabant (SR141716A).
Diergaarde L; de Vries W; Raasø H; Schoffelmeer AN; De Vries TJ
Neuropharmacology; 2008 Oct; 55(5):712-6. PubMed ID: 18588903
[TBL] [Abstract][Full Text] [Related]
4. Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.
Nawata Y; Kitaichi K; Yamamoto T
Drug Alcohol Depend; 2016 Mar; 160():76-81. PubMed ID: 26796595
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking.
Gamaleddin I; Wertheim C; Zhu AZ; Coen KM; Vemuri K; Makryannis A; Goldberg SR; Le Foll B
Addict Biol; 2012 Jan; 17(1):47-61. PubMed ID: 21521420
[TBL] [Abstract][Full Text] [Related]
6. Effects of cannabinoid CB₁ receptor antagonist rimonabant on acquisition and reinstatement of psychostimulant reward memory in mice.
Yu LL; Zhou SJ; Wang XY; Liu JF; Xue YX; Jiang W; Lu L
Behav Brain Res; 2011 Feb; 217(1):111-6. PubMed ID: 20937331
[TBL] [Abstract][Full Text] [Related]
7. Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
Schindler CW; Redhi GH; Vemuri K; Makriyannis A; Le Foll B; Bergman J; Goldberg SR; Justinova Z
Neuropsychopharmacology; 2016 Aug; 41(9):2283-93. PubMed ID: 26888056
[TBL] [Abstract][Full Text] [Related]
8. Suppression by the cannabinoid CB1 receptor antagonist, rimonabant, of the reinforcing and motivational properties of a chocolate-flavoured beverage in rats.
Maccioni P; Pes D; Carai MA; Gessa GL; Colombo G
Behav Pharmacol; 2008 May; 19(3):197-209. PubMed ID: 18469537
[TBL] [Abstract][Full Text] [Related]
9. Effects of the cannabinoid CB₁ receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats.
Jing L; Qiu Y; Zhang Y; Li JX
Drug Alcohol Depend; 2014 Oct; 143():251-6. PubMed ID: 25169627
[TBL] [Abstract][Full Text] [Related]
10. The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.
Adamczyk P; Miszkiel J; McCreary AC; Filip M; Papp M; Przegaliński E
Brain Res; 2012 Mar; 1444():45-54. PubMed ID: 22325096
[TBL] [Abstract][Full Text] [Related]
11. Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats.
Economidou D; Mattioli L; Cifani C; Perfumi M; Massi M; Cuomo V; Trabace L; Ciccocioppo R
Psychopharmacology (Berl); 2006 Jan; 183(4):394-403. PubMed ID: 16261315
[TBL] [Abstract][Full Text] [Related]
12. Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys.
Schindler CW; Scherma M; Redhi GH; Vadivel SK; Makriyannis A; Goldberg SR; Justinova Z
Psychopharmacology (Berl); 2016 May; 233(10):1867-77. PubMed ID: 26803499
[TBL] [Abstract][Full Text] [Related]
13. The cannabinoid CB1 receptor antagonist AM251 does not modify methamphetamine reinstatement of responding.
Boctor SY; Martinez JL; Koek W; France CP
Eur J Pharmacol; 2007 Sep; 571(1):39-43. PubMed ID: 17628534
[TBL] [Abstract][Full Text] [Related]
14. Effects of the MCH1 receptor antagonist SNAP 94847 on high-fat food-reinforced operant responding and reinstatement of food seeking in rats.
Nair SG; Adams-Deutsch T; Pickens CL; Smith DG; Shaham Y
Psychopharmacology (Berl); 2009 Jul; 205(1):129-40. PubMed ID: 19340414
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats.
Fattore L; Spano S; Cossu G; Deiana S; Fadda P; Fratta W
Neuropharmacology; 2005 Jun; 48(8):1097-104. PubMed ID: 15910886
[TBL] [Abstract][Full Text] [Related]
16. Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats.
Li F; Fang Q; Liu Y; Zhao M; Li D; Wang J; Lu L
Eur J Pharmacol; 2008 Jul; 589(1-3):122-6. PubMed ID: 18534572
[TBL] [Abstract][Full Text] [Related]
17. Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade.
Anggadiredja K; Nakamichi M; Hiranita T; Tanaka H; Shoyama Y; Watanabe S; Yamamoto T
Neuropsychopharmacology; 2004 Aug; 29(8):1470-8. PubMed ID: 15085091
[TBL] [Abstract][Full Text] [Related]
18. Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.
Fattore L; Spano M; Melis V; Fadda P; Fratta W
Br J Pharmacol; 2011 Aug; 163(7):1550-62. PubMed ID: 21518339
[TBL] [Abstract][Full Text] [Related]
19. Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant.
Justinova Z; Munzar P; Panlilio LV; Yasar S; Redhi GH; Tanda G; Goldberg SR
Neuropsychopharmacology; 2008 Nov; 33(12):2870-7. PubMed ID: 18305459
[TBL] [Abstract][Full Text] [Related]
20. SLV330, a cannabinoid CB(1) receptor antagonist, attenuates ethanol and nicotine seeking and improves inhibitory response control in rats.
de Bruin NM; Lange JH; Kruse CG; Herremans AH; Schoffelmeer AN; van Drimmelen M; De Vries TJ
Behav Brain Res; 2011 Mar; 217(2):408-15. PubMed ID: 21074574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
